Health Care · Electromedical & Electrotherapeutic Apparatus · Nasdaq · CIK 1639691 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $81.05Day −0.47%Mkt cap $4.5B1Y +84.2%Off 52W high −4.9%Vol (1Y) 38.4%
Daily closing price, split-adjusted to the current basis; 3y shown of 2,708 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest7.4% of sh out |
| Days to cover7.2d |
| 13F net flow (QoQ)+4.47% |
| Top-10 13F concentration48.8% |
| Next report (est.)2026-08-05 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$1.43B |
| Earnings (TTM)$107.1M |
| ROE−19.2% |
| Net margin−17.5% |
| ROIC12.8% |
| Debt / equity0.31× |
| Sales growth 3Y10.8% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+31.7% |
| 1Y+84.2% |
| 3Y+38.7% |
| 5Y−6.1% |
| 10Y+46.4% |
| Since incept. (ann.)+1.4% |
Total return through 2026-07-30 · series begins 2015-10-19. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)38.4% |
| Ann. volatility (3Y)39.9% |
| Sharpe (1Y)1.79 |
| Sharpe (3Y)0.47 |
| Max drawdown (1Y)−18.9% |
| Max drawdown (3Y)−47.2% |
| Beta (3Y vs SPY)0.84 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| BlackRock, Inc. | 7.1M | $454M | 13.05% | −2.5% |
| PRIMECAP MANAGEMENT CO/CA/ | 4.2M | $267M | 7.69% | −0.4% |
| FMR LLC | 2.7M | $169M | 4.88% | +5711.9% |
| MILLENNIUM MANAGEMENT LLC | 2.4M | $155M | 4.46% | −30.0% |
| AQR CAPITAL MANAGEMENT LLC | 2.5M | $154M | 4.56% | +15.7% |
| Artisan Partners Limited Partnership | 2.1M | $135M | 3.88% | −8.3% |
| STATE STREET CORP | 2.1M | $132M | 3.79% | +3.0% |
| WELLINGTON MANAGEMENT GROUP LLP | 1.9M | $120M | 3.46% | −6.2% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total. Institutional 13F holdings sum to 107.4% of shares outstanding. Readings above 100% reflect securities-lending double counting: shares on loan to short sellers are reported long by both the lending institution and the one that bought them. FINRA short interest of 3,381,707 shares (settlement 2026-04-30) accounts for the excess.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-06 | $0.40 | — | $362.3M | +14.3% |
| 2025-12-31 | 2026-02-25 | — | — | $360.9M | +12.1% |
| 2025-09-30 | 2025-11-05 | $0.49 | −18.3% | $357.8M | +12.5% |
| 2025-06-30 | 2025-08-06 | $0.50 | +66.7% | $352.5M | +10.7% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-05 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
US 51% · Locations Excluding The United States And Europe 26% · Europe 19% · GB 4%
geographic · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
